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Autophagy (more precisely, macroautophagy) is a sequential process 
through which cells degrade long-lived proteins and cytoplasmic 
organelles, providing their constituents for recycling (1–3). Organ-
elles destined for degradation are first sequestered in vacuoles 
called autophagosomes, which then fuse with late endosomes, 
forming amphisomes, and finally with lysosomes, forming autol-
ysosomes. Material within autolysosomes is degraded by hydro-
lases, the most important class of which is the cathepsin family of 
proteases (4, 5). Cathepsins, such as cathepsin L (CatL) and CatB, 
undergo proteolytic processing during their transit from the Golgi 
complex to lysosomes, to become mature active enzymes (6–9). 
Autophagy is an adaptive response; starvation is one of its stron-
gest physiological triggers. In response to starvation, autophagy 
mediates degradation of nonessential components and thus gen-
erates vital nutrients, such as amino acids (1, 3). Defects in the 
initiation of autophagy or its progression/resolution (“autophagic 
flux”) are associated with a number of disorders, most prominent-
ly neurodegenerative diseases (3, 10, 11).
Pancreatitis is a potentially lethal inflammatory disease of the 
pancreas. Its pathogenesis remains obscure and specific treatments 
have not been developed. Accumulation of large vacuoles in acinar 
cells is a prominent and early feature of pancreatitis (12–18); how-
ever, the nature of these vacuoles, their mechanism of formation, 
and their relation to other pathological responses of pancreatitis 
have not been established. Another early response of pancreatitis is 
the pathological, intra-acinar cell activation of digestive enzymes, 
especially trypsinogen. Trypsinogen activation (i.e., its conversion 
from inactive zymogen to trypsin) has been found clinically and in 
experimental models of acute pancreatitis and is considered a criti-
cal disease-initiating event (19–24). The mechanism of the intra-
acinar trypsinogen activation remains poorly understood. The cur-
rent paradigm (19, 22, 23) is that it is catalyzed by CatB that has 
“missorted” and thus becomes colocalized with trypsinogen in as 
yet unidentified compartment(s).
The role of autophagy and its possible defects in pancreatitis is 
only starting to be elucidated. In particular, a recent study (25) using 
mice deficient in Atg5, a key autophagy protein, proposed that exces-
sive autophagy is the cause of intra-acinar trypsinogen activation.
In the present study, we provide evidence that autophagy is 
impaired in pancreatitis and that impaired autophagy mediates 
both acinar cell vacuolation and the pathological, intra-acinar 
trypsin accumulation. We used in vivo and in vitro experimental 
models to show that autophagy is activated by both pancreatitis 
and fasting, but, unlike fasting, acute pancreatitis causes inhibi-
tion of lysosomal degradation and retardation of autophagic flux. 
We further found that pancreatitis impairs processing/maturation 
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and activities of CatL and CatB, which may underlie the inefficient 
lysosomal degradation. Our results indicate that this dysfunction, 
rather than missorting of Cat B (19, 22, 23) or excessive autophagy 
(25), mediates the intra-acinar accumulation of active trypsin.
Results
Autophagic flux is impaired in acute pancreatitis
Autophagy is activated and is involved in vacuole accumulation in acinar 
cells, a key pathological response of acute pancreatitis. We first examined 
acinar cell vacuolation in different experimental models of pancre-
atitis as well as in human tissue with EM (Figure 1, A–C; see larger 
fields in the Supplemental Figure 1; supplemental material avail-
able online with this article; doi:10.1172/JCI38674DS1). Numer-
ous vacuoles containing nondegraded or partially degraded mate-
rial (including zymogen granules [ZGs]) were seen in acinar cells in 
all models examined (see Methods), namely pancreatitis induced in 
rats by cerulein (CR) or l-arginine (Arg); in mice, by feeding them 
choline-deficient, ethionine-supplemented diet (CDE); and in iso-
lated acinar cells hyperstimulated with CCK-8 (CCK) (in vitro model 
of pancreatitis). Vacuoles with partially degraded cellular material 
were also seen on electron micrographs of human pancreas from a 
patient with acute pancreatitis (Figure 1A and Supplemental Fig-
ure 1). Of note, these vacuoles were often large, even larger than the 
nucleus (e.g., in CR and Arg pancreatitis). The presence of partially 
digested material is a hallmark of autophagic vacuoles (1, 3, 26). 
Also, the vacuoles accumulated in pancreatitis have double mem-
branes (Figure 1B), another characteristic of autophagic vacuoles 
(2, 26, 27). Further, immunogold EM (Figure 1C) demonstrated 
the presence of the microtubule-associated protein 1 light chain 3 
(LC3; the mammalian ortholog of yeast Atg8), a specific marker of 
autophagic vacuoles (28), in pancreatic acinar cells. Of note, acinar 
cells in pancreatitis contained both of the 2 morphologically dis-
tinct types of vacuoles that are classified in autophagy research as 
early, initial autophagic vacuoles (AVi; mostly autophagosomes), 
containing intact sequestered material, and late, degradative 
autophagic vacuoles (AVd; mostly autolysosomes), containing par-
tially degraded but identifiable cargo (1, 29). As shown in Figure 
1A, the CR pancreatitis panel presents examples of both types of 
autophagic vacuoles in the same acinar cell.
As further evidence that autophagy is activated in pancreatitis, 
we showed by immunoblot that pancreatic level of beclin1 (Atg6), 
a key autophagy mediator (1, 2), greatly increased in CR pancre-
atitis (Figure 1D).
Figure 1
Autophagy is activated in acute pancreatitis and is involved in acinar cell vacuolation. (A) Electron micrographs showing autophagic vacuoles 
(arrowheads) in pancreatic tissue (or isolated acinar cells) from experimental models of pancreatitis (see Methods) and in pancreas of a patient 
with acute pancreatitis. Shown is pancreatitis induced in rats by CR or Arg, in mice by CDE, and the in vitro model of acinar cells hyperstimulated 
with CCK. N, nucleus. Larger fields and higher-magnification images are shown in Supplemental Figure 1. (B) Electron micrograph demonstrat-
ing the double membrane (arrowhead), a characteristic of autophagosomes, in CR pancreatitis. (C) Electron micrograph illustrating LC3 immu-
nogold localization (arrowheads) to an autophagic vacuole in pancreas of a GFP-LC3 transgenic mouse with CR pancreatitis. (D) Pancreatic 
level of beclin1 increased in CR pancreatitis (immunoblot). ERK1/2 served as loading control. (E and F) Inhibiting autophagy with 3-MA or Atg5 
siRNA greatly decreased vacuolation in acinar cells hyperstimulated with CCK. (E) Rat acinar cells were incubated for 3 hours with or without 
100 nM CCK and 10 mM 3-MA. Vacuoles were counted in cells stained with toluidine blue. (F) Mouse acinar cells were transfected with Atg5 siRNA 
or control siRNA (see Methods), and then incubated for 3 hours with and without 100 nM CCK. The inset illustrates transfection efficiency. Cells 
were immunostained for LC3, and vacuoles (LC3 dots) were counted under confocal microscope using ImageJ software. Values (mean ± SEM) 
are from at least 1,000 cells for each condition (E and F). *P < 0.05 versus control cells; #P < 0.05 versus CCK alone.
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To quantify the contribution of autophagy to acinar cell vacuola-
tion, we measured the effects on vacuole accumulation of blocking 
autophagy with a specific inhibitor, 3-methyladenine (3-MA), or 
by using siRNA against Atg5, a protein important for autophagy 
induction (2, 28). Both 3-MA (Figure 1E) and Atg5 siRNA trans-
fection (Figure 1F) substantially inhibited acinar cell vacuolation 
induced by supramaximal CCK (the in vitro model of pancreatitis). 
These results are in accord with a recent study (25), showing that 
acinar cell vacuolation in CR pancreatitis was greatly inhibited in 
Atg5-deficient mice.
The results in Figure 1 (and those of ref. 25) indicate that 
autophagy is activated in acute pancreatitis and is involved in aci-
nar cell vacuolation, a key pathological response of pancreatitis. 
Vacuole accumulation could be a result of enhanced autophagy or 
impaired progression/resolution (flux) of autophagy (3). There-
fore, we asked whether acinar cell vacuolation — as well as other 
pathological responses — are caused by activation of autophagy or 
by its disordering in pancreatitis. For this purpose, we compared 
autophagy in models of pancreatitis with the “classic” physiologi-
cal autophagy response induced by starvation (fasting). Of note, 
fasting has been recently shown (28) to potently activate autopha-
gy in exocrine pancreas.
Compared with fasting, autophagic vacuoles induced by pancreatitis are 
greater in number and much larger. Western blot analysis showed that 
both fasting and pancreatitis stimulated LC3 conversion in pan-
creas from the cytosolic (~18 kDa) LC3-I to vesicular (~16 kDa) 
Figure 2
Compared with fasting, pancreatitis-induced autophagic vacuoles are greater in number and much larger. (A) LC3-I to LC3-II conversion 
(immunoblot) in pancreas of rats under conditions of fasting (for 17 hours) and pancreatitis (see Methods). ERK1/2 served as loading control. 
(B) Colocalization of the autophagy marker LC3 with amylase, a ZG marker, under conditions of fasting and CR pancreatitis. Pancreatic tissue 
sections were double immunostained for LC3 and amylase. Images were visualized under confocal microscope. Larger boxes show expanded 
images of the areas indicated by smaller boxes. (C) Effects of fasting and pancreatitis on LC3 dots in pancreas, as shown in B. The number of 
LC3 dots was normalized to that of nuclei in the same field. (D) Autophagic vacuoles were identified on electron micrographs (see Figure 1), and 
their size was measured relative to the average size of nuclei on the same micrograph. (E) Acinar cell vacuolation on H&E-stained pancreatic 
tissue sections from rats under conditions of fasting or CR pancreatitis (original magnification, ×40) and from a patient with acute pancreatitis 
(a gift from D.S. Longnecker; original magnification, ×60). (F). Cross-sectioned area of pancreas occupied by vacuoles was quantified on 
H&E-stained sections using MetaMorph 6 software. Values in C, D, and F are (mean ± SEM) from 3–5 rats for each condition. In C and F, at 
least 1,000 acinar cells were counted for each animal. In D, 20–30 acinar cells from at least 3 rats were counted for each condition. *P < 0.05 
versus fed rats; #P < 0.02 versus fasting rats.
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LC3-II form, which uniquely marks the autophagosomal and 
amphisomal membranes (Figure 2A and Supplemental Figure 2). 
Similar results for mouse CR pancreatitis were reported in ref. 25. 
The extent of LC3 conversion in both CR and Arg pancreatitis was 
much greater than in pancreas of rats fasted overnight (Figure 2A) 
or up to 64 hours (Supplemental Figure 2). Of note, pancreatic 
LC3-II levels decreased rather than increased over the duration of 
fasting (Supplemental Figure 2).
As is commonly done, CR pancreatitis was induced in rats 
fasted overnight (for 17 hours). This approach, namely the use 
of overnight fasted animals, is applied in models of CCK- or CR-
induced pancreatitis to avoid the effect of variable secretion dur-
ing the nocturnal feeding period (e.g., refs. 30, 31). The extent 
of LC3 conversion in pancreas (as well as other parameters of 
autophagy) was similar in rats either fasted for 17–24 hours or 
fasted overnight and then used as saline-injected controls for CR 
pancreatitis (Figure 2A).
Both fasting and pancreatitis increased the number of punc-
tate, vesicular LC3-immunopositive structures (“LC3 dots”; ref. 
27) in pancreas. LC3 dots in pancreas partly colocalized with 
amylase, a major digestive enzyme contained in ZGs of acinar 
cells (Figure 2B). This confirms EM data (Figure 1A and Sup-
plemental Figure 1), demonstrating ZGs sequestered within 
autophagic vacuoles. In both CR and Arg pancreatitis, the num-
ber of LC3 dots representing autophagic vacuoles increased 
2.0–2.5 times more than that with fasting (Figure 2C). Using 
transgenic GFP-LC3 mice (28), we confirmed that the increase 
in the number of GFP-LC3 dots was much greater in CR pancre-
atitis than that with fasting (data not shown).
Autophagic vacuoles induced by pancreatitis and fasting exhib-
ited a striking difference in size. EM showed that the average cross-
sectional area of autophagic vacuoles in pancreas of rats with CR 
pancreatitis was more than 100 times larger than those in fasting 
conditions (Figure 2D). In agreement with the EM data, quantifi-
cation of total vacuoles on H&E-stained pancreatic tissue sections 
showed that both their number and the area occupied by vacuoles 
were much greater in CR or Arg pancreatitis than with fasting (Fig-
ure 2, E and F; and data not shown).
Autophagy-mediated degradation of long-lived proteins is inhibited in 
the in vitro model of pancreatitis. Accumulation of large autopha-
gic vacuoles could be an indication of impaired flux through 
autophagy pathway, that is, impaired progression from autopha-
gosomes to autolysosomes and inefficient autophagic protein 
clearance (3). To address this issue, we measured the rate of 
long-lived protein degradation, a key parameter of autophagy 
efficiency (27), in conditions of in vitro pancreatitis (Figure 3). 
For this assay (see Methods), we used prolonged primary cul-
ture of mouse pancreatic acinar cells (32), described in detail in 
Methods. Cells were first cultured for 6 hours in the presence of 
[14C]-valine to label proteins and then chased for 16 hours in 
fresh medium containing “cold” valine. Cells were then incubat-
ed with either physiological (10 pM) or supramaximally stimu-
lating (100 nM) CCK (as well as vehicle) in both the regular 199 
medium (containing amino acids) or a nutrient-free medium 
(devoid of amino acids), which is commonly used for “in vitro 
starvation” experiments (33). This experimental design aimed to 
measure the effects of physiological versus supramaximal CCK 
and compare those with that of amino acid withdrawal, which 
has been shown (33) to trigger autophagy responses and stimu-
late protein degradation in other cells. To determine the fraction 
of protein degradation that is autophagy independent, parallel 
incubations were performed for each condition in the presence 
or absence of the autophagy inhibitor 3-MA (10 mM) (27). Sub-
tracting the values obtained in the presence of 3-MA (from those 
obtained without 3-MA) provides the autophagy-mediated net 
rate of long-lived protein degradation.
These experiments yielded several salient findings (Figure 3, A and 
B). First, starvation (i.e., nutrient-free medium) increased the rate 
of autophagy-mediated protein degradation in acinar cells approxi-
mately 1.7 fold. This increase, as well as the basal rate of protein 
degradation (~7% over 4 hours), is similar to that reported for other 
cell types (34). Second, whereas the physiological CCK concentra-
tion slightly stimulated protein degradation, the supramaximal 
CCK markedly inhibited autophagy-mediated protein degrada-
tion in acinar cells (Figure 3A). Third, the autophagy-independent 
(“3-MA resistant”) part of protein degradation was the same in all 
4 conditions, at both 2-hour and 4-hour time points; that is, it was 
not affected by CCK. Finally, the CCK-induced inhibition of pro-
tein degradation was associated with accumulation of LC3-positive 
vacuoles in acinar cells (Figure 3B). Thus, CCK hyperstimulation 
of acinar cells (in vitro model of pancreatitis) caused a decrease in 
protein degradation, concomitant with accumulation of autopha-
gic vacuoles. These findings strongly indicate that in contrast to 
starvation, efficient progression of autophagy (autophagic flux) is 
impaired in pancreatitis.
Figure 3
Starvation increases, but CCK hyperstimulation decreases autophagy-
mediated protein degradation in pancreatic acinar cells. (A) Autoph-
agy-mediated degradation of long-lived proteins was measured in 
mouse pancreatic acinar cells by pulse-chase assay, as described in 
Methods. Briefly, the culture medium was supplemented for the first 
6 hours with [14C]-valine to label proteins, after which cells were chased 
for 16 hours in fresh medium containing cold valine. Cells were then 
switched to either (ii–iv) medium 199 containing amino acids or (i) 
nutrient-free (i.e., free of amino acids) medium, and further cultured for 
4 hours with 0.1 nM (ii) or 100 nM (iv) CCK, or without CCK (i and iii), 
both in the presence and absence of 10 mM 3-MA. Protein degradation 
was measured as the net release of TCA-soluble radioactivity; values 
obtained in the presence of 3-MA were subtracted as nonautophagic 
background. The measurements were in duplicates, and the experi-
ment was repeated with similar results. Data represent mean ± SEM. 
(B) Quantification of LC3 dots in acinar cells incubated in conditions iii 
and iv described in A (that is, control versus 100 nM CCK). LC3 dots 
were visualized under confocal microscope as illustrated in Figure 2B 
and counted, with the use of ImageJ software, in at least 1,000 acinar 
cells for each condition. Values are mean ± SEM (n = 4).
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In pancreatitis, lysosomal markers accumulate in the heavier, ZG-enriched 
subcellular fraction. To further examine the effects of pancreatitis on 
autophagic flux, we studied the distribution of lysosomal markers 
in subcellular fractions obtained from pancreas of rats subjected 
to pancreatitis or fasting (Figure 4 and Supplemental Figure 3). 
The method of pancreatic tissue fractionation was introduced 
more than 30 years ago (35) and modified by Steer and Saluja (30, 
36). Briefly, pancreatic tissue homogenate was subjected to differ-
ential centrifugation to form 3 fractions: (a) 1,300-g pellet, which 
was enriched in ZGs (fraction Z); (b) 12,000-g pellet, which was 
enriched in lysosomes (fraction L); and (c) 12,000-g supernatant, 
containing early endosomes, ER, and cytosolic proteins (fraction 
E). In accordance with the published EM data (36), we confirmed 
(Figure 4A; see larger fields in Supplemental Figure 3) that in our 
preparations from normal rat pancreas, fraction Z was greatly 
enriched in ZGs and also contained mitochondria, while fraction 
L contained lysosomes, some mitochondria, and mostly ER. We 
further visualized lysosomes in fraction L, by using the specific 
vital stain LysoTracker Red (Figure 4A). The LysoTracker staining, 
as well as staining of mitochondria with another vital probe, Mito-
Tracker Red (data not shown), confirmed that our preparations 
contained intact organelles.
To further characterize the nature of the subcellular fractions, 
we used Western blot analysis to detect markers specific for dif-
ferent organelles. The results (Figure 4B) are consistent with the 
EM data (Supplemental Figure 3) and demonstrate, for example, 
that trypsinogen, a major zymogen, was enriched in fraction Z and 
also present in fraction E; fraction Z contained little ER; and early 
endosomes were only present in fraction E. The vesicular material 
in fraction E is also shown by EM (Supplemental Figure 3). LC3-II 
immunoblot showed that autophagic vacuoles are in fractions Z 
and L (Figure 4C). Colocalization of punctate LC3 with amylase 
Figure 4
In pancreatitis, lysosomal markers accumulate in a heavier, ZG-enriched subcellular fraction. (A and B) Characterization of pancreatic tissue 
subcellular fractions. Rat pancreas homogenate was fractionated by differential centrifugation, as described in Methods, to obtain 1,300-g pellet 
enriched in ZGs (fraction Z [Z]); 12,000-g pellet enriched in lysosomes (fraction L [L]); and 12,000-g supernatant containing early endosomes 
and cytosolic proteins (fraction E [E]). (A) The indicated subcellular fractions were analyzed under electron microscope or under fluorescence 
microscope using the lysosomal vital stain LysoTracker Red. Original magnification: ×7,500 (left panel); ×12,500 (center panel); ×40 (right panel). 
Larger EM fields are shown in the Supplemental Figure 3. (B) Subcellular fractions from normal rat pancreas were analyzed by immunoblot 
using antibodies against proteins specific for the organelles listed to the right. COX IV, cytochrome c oxidase subunit IV; PDI, protein disulfide 
isomerase; EEA1, early endosomal antigen. (C and E) Rats were subjected to conditions of fasting and pancreatitis induced by CR or Arg, as 
described in Methods. The levels of LC3-II, Rab7, LAMP-1, and LAMP-2 were measured by immunoblot in pancreatic tissue subcellular frac-
tions. For each protein, the same amount of protein was loaded in all samples. The data are representative of several immunoblots from at least 
3 rats for each condition. (D) Colocalization of the autophagic marker LC3 with amylase in fraction Z, obtained from a rat with CR pancreatitis, 
was determined by double staining with anti-LC3 antibody and FITC-conjugated secondary antibody (for LC3 dots) and with amylase antibody 
and Texas Red–conjugated secondary antibody. Original magnification: ×63.
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in fraction Z, both in normal rat pancreas (data not shown) and 
CR pancreatitis (Figure 4D), further indicated that some of the 
autophagic vacuoles in fraction Z contain ZG.
We next measured the effects of fasting and pancreatitis on the 
subcellular distribution of the lysosome-associated membrane pro-
tein-1 (LAMP-1) and LAMP-2 as well as Rab7 (Figure 4E). LAMP-1 
and LAMP-2 are major lysosomal integral membrane proteins but 
are also present in prelysosomal structures, whereas Rab7 is spe-
cific for lysosomes and late endosomes (29, 37). We found that 
fasting did not cause significant changes in the subcellular distri-
bution of these proteins in pancreas, compared with that in fed 
rats. Thus, in both fed and fasted animals, the LAMPs and Rab7 
were mostly in the lysosome-enriched fraction L (there was also a 
substantial amount of LAMP-2 in fraction E). In contrast, CR and 
Arg pancreatitis induced dramatic increases in all 3 proteins in the 
heavier, ZG-enriched fraction Z (Figure 4E). Notably, the apparent 
molecular weight of Rab7 localized to fraction Z in CR pancreatitis 
was different from that of the “basal” form of Rab7 protein pres-
ent in fraction L (Figure 4E).
A logical explanation for the pancreatitis-induced shift of lyso-
somal markers to the heavier fraction Z is that it is caused by 
retarded autophagy progression, resulting in accumulation of 
Figure 5
Colocalization of lysosomal markers Rab7, LAMP-2, or CatB with the autophagosomal marker LC3 increases in models of pancreatitis. Rats 
were subjected to conditions of fasting and pancreatitis induced by CR or Arg, as described in Methods. (A, C, and E). Pancreatic tissue sections 
were double stained with anti-LC3 antibody and FITC-conjugated secondary antibody (for LC3 dots) and with a primary antibody against Rab7 
(A), LAMP-2 (C), or CatB (E) and Texas Red-conjugated secondary antibody. Images were visualized under confocal microscope. (B, D, and 
F). Colocalization of Rab7, LAMP-2, or CatB with LC3 was quantified with the use of ImageJ software. Values are (mean ± SEM) from at least 
3 animals for each condition. *P < 0.05 versus normally fed rats; #P < 0.05 versus fasting rats.
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heavy autolysosomes containing partially degraded cargo. This 
conclusion is consistent with our finding that pancreatitis causes 
inhibition of autophagic protein degradation and accumulation 
of large vacuoles in acinar cells (Figure 3). The dramatic increase in 
LC3-II level in fraction L observed in CR pancreatitis (Figure 4C) is 
also consistent with retarded autophagic flux.
Rab7 levels in whole pancreatic tissue were upregulated in both 
CR and Arg pancreatitis (Supplemental Figure 4), in accordance 
with the changes observed on subcellular fractions. Moreover, CR 
but not Arg pancreatitis caused a dramatic increase in both lower 
and upper bands of Rab7 doublet (Supplemental Figure 4), corre-
sponding to the appearance of the higher-molecular-weight Rab7 
band in fraction Z (Figure 4E). The effects of pancreatitis on total 
levels of LAMP-1 were less dramatic (Supplemental Figure 4) and 
in accordance with the results on subcellular fractions.
Pancreatitis does not block the fusion of autophagosomes with late endo-
somes/lysosomes. One possible explanation for the impaired autoph-
agy progression in pancreatitis could be blockade of the fusion 
between autophagosomes and late endosomes/lysosomes, a com-
mon defect in lysosomal diseases (3, 10). However, this mechanism 
does not appear to account for the defect in pancreatitis. We found 
that the colocalization of the autophagosomal marker 
LC3-II with the lysosomal markers Rab7 or LAMP-2 
(as well as with CatB) markedly increased in pancre-
atitis (Figure 5). Compared with that in feeding condi-
tions, fasting did not change Rab7 colocalization with 
LC3 (Figure 5B), and it increased the colocalization of 
LAMP-2 (Figure 5D) and CatB (Figure 5F) with LC3 
significantly less than pancreatitis.
The results in Figure 5 indicate that the fusion 
between autophagosomes and late endosomes/lyso-
somes was not blocked in pancreatitis. This is in 
agreement with our EM data that demonstrate a 
great number of vacuoles with partially degraded 
material in various models of pancreatitis (Figure 1 
and Supplemental Figure 1). Thus, the data suggest 
that the defective autophagic protein degradation we 
observe in pancreatitis is not caused by a blockade of 
formation of autolysosomes but could be caused by 
decreased lysosomal function, that is, decreased activ-
ity of lysosomal hydrolases. To examine this issue, we 
assessed the effects of pancreatitis and fasting on the 
processing and activities of CatL and CatB, which are 
important for autophagic function (3). CatB is rele-
vant for the mechanism of pancreatitis, because there 
is compelling evidence (19, 21, 22, 24, 38, 39) that it is 
a key activator of the pathological, intra-acinar con-
version of trypsinogen to trypsin. Although CatL is 
present in human and rodent pancreas, there is little 
known on its role in pancreatitis (40–42).
Processing and activities of CatL and CatB are 
dysregulated in acute pancreatitis
Processing of CatL and CatB is impaired in pancreatitis, 
and active forms of CatL (but not CatB) accumulate in ZG-
enriched subcellular fraction. Cathepsins are activated 
through sequential proteolytic cleavage of their inac-
tive proform. First, they are partially processed into a 
“single-chain” form, which is then cleaved into a heavy 
and light chain. These, in turn, form a noncovalent 
complex (“double-chain” form), representing the fully mature 
cathepsin (5–8). Fully mature, double-chain cathepsins are usu-
ally formed in lysosomes, whereas partially processed (e.g., single-
chain) active forms can also be present in prelysosomal structures 
(5, 9). Defects in cathepsin processing/maturation may lead to 
impaired lysosomal protein clearance, as observed in some neuro-
degenerative lysosomal disorders (10).
We examined the effects of pancreatitis and fasting on cathepsin 
processing by immunoblot (Figure 6), using antibodies that recog-
nize the proform, the partially processed (single-chain) form, and 
the heavy chain of the fully matured (double-chain) CatL and CatB. 
(Of note, there are few examples of immunoblots for these cathep-
sins in tissues and almost none in pancreas [ref. 43].) Fasting did 
not cause significant changes in the band profile of CatL, either 
in the whole pancreatic tissue (Figure 6A) or subcellular fractions 
(Figure 6B). In pancreas of both fasted and fed rats, the active CatL 
was only present in its fully mature, double-chain (~25 kDa) form, 
which was predominantly in the lysosome-enriched fraction L.
In contrast, CR and Arg pancreatitis caused the appearance in 
rat pancreas of a partially processed form of CatL (Figure 6A). 
Based on its apparent molecular weight (~32 kDa), this intermedi-
Figure 6
Pancreatitis but not fasting impairs processing/maturation of CatL and CatB. Rats 
were subjected to conditions of fasting and pancreatitis induced by CR or Arg, as 
described in Methods. Levels of CatL and CatB were measured by immunoblot in 
(A and C) whole pancreatic tissue or (B and D) pancreatic subcellular fractions, 
obtained as in Figure 4. ERK1/2 served as loading control. For each cathepsin, 
the same amount of protein was loaded in all samples. The data are representa-
tive of several immunoblots from at least 3 rats for each condition. p, cathepsin 
proform; i, intermediate form; sc, the single-chain form; dc, the fully processed, 
double-chain form.
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ate form likely represents the single-chain CatL. In CR pancreati-
tis, the intermediate form appeared in all 3 subcellular fractions, 
whereas in the Arg model, it was mostly in fraction Z (Figure 6B). 
Further, pancreatitis caused dramatic accumulation of active CatL 
forms, both the partially (single-chain form) and fully processed 
(double-chain form), in the ZG-enriched fraction Z (Figure 6B). 
In Arg pancreatitis, the increase in the double-chain CatL was not 
only in fraction Z but also L (Figure 6B). Another distinct effect of 
Arg pancreatitis was a CatL decrease in fraction E.
CatB band profiles in normal rat pancreas (Figure 6, C and D) 
were very different from CatL. First, CatB proform appeared on 
immunoblot as doublet or triplet bands; these multiple bands 
may correspond to forms varying in phosphorylation (44). Sec-
ond, active (processed) CatB was present as both the single- and 
double-chain forms (based on their apparent molecular weight of 
~31 and ~27 kDa, respectively). Third, the active forms of CatB 
were equally distributed in all 3 fractions (Figure 6D). Of note, the 
profile of CatB bands was distinct for each fraction. For example, 
in the lysosome-enriched fraction L there was more double- than 
single-chain CatB, and the double-chain form was manifest as a 
doublet (Figure 6D). (The doublet may represent heavy chains dif-
fering in the extent of glycosylation [ref. 45]. The distinct CatB 
band patterns in subcellular fractions indicate that there was little 
cross-contamination among the fractions.)
Fasting did not affect CatB processing, as shown by CatB band pro-
files in whole pancreas (Figure 6C) and subcellular fractions (Figure 
6D). In contrast, in both models of pancreatitis, there was a decrease 
in the double-chain form of CatB in pancreas (Figure 6C). Arg pan-
creatitis displayed a decrease in both the double- and single-chain 
CatB forms. The subcellular fractions immunoblots (Figure 6D) 
showed that pancreatitis-induced decrease in the double-chain CatB 
was in fractions Z and E. In the Arg model, fraction E displayed a dra-
matic decrease in both the double- and single-chain CatB forms.
Thus, pancreatitis appears to affect the processing (maturation) of 
key lysosomal enzymes. The major effects on CatL were the appear-
ance of its partially processed (single-chain) form and the accumu-
lation of active CatL forms in the heavier, ZG-enriched fraction Z. 
The main effect of pancreatitis on CatB was a decrease in its fully 
mature form. Importantly, however, there was no redistribution of 
CatB from fraction L to Z in any model of pancreatitis. As shown in 
Figure 6, cathepsins processing/maturation is profoundly impaired 
in acute experimental pancreatitis, resulting in a shift toward imma-
ture CatL and CatB forms. Such impairment may cause deficient 
lysosomal protein clearance and retarded autophagic flux.
Pancreatitis but not fasting greatly decreases CatB and CatL activities 
in the lysosome-enriched subcellular fraction. Neither pancreatitis nor 
fasting markedly affected CatL and CatB activities in the whole 
pancreas, compared with those in fed conditions (data not shown). 
Previously, a similar result has been reported for CatB in CR pan-
creatitis (36). However, pancreatitis and fasting had dramatically 
different effects on activities of cathepsins in the subcellular frac-
tions (Figure 7). Overall, fasting had little effect, and the maxi-
mal activity of cathepsins in pancreas of fasted rats was in the 
lysosome-enriched fraction L — same as that in normally fed rats 
(Figure 7A). In contrast, both CR and Arg pancreatitis caused a 
dramatic decrease in CatL and CatB activities in fraction L, so that 
the maximal activity shifted to the heavier, ZG-enriched fraction 
Z (Figure 7A). This was accompanied by a moderate increase in 
activities of cathepsins in fraction Z (see Figure 7, A and B).
For CatB, a similar shift in maximal activity from fraction L to 
Z was previously reported in CR model (30, 36) and interpreted as 
redistribution (missorting) of CatB to the ZG-containing fraction. 
However, changes in cathepsin activity in a given fraction could 
result from changes in either its level or the enzyme’s “molecular” 
activity. Our immunoblot data showed that pancreatitis did not 
cause any significant redistribution of CatB from fraction L to Z 
(Figure 6D), arguing against missorting of CatB to the ZG-con-
taining fraction. Therefore, we next examined whether pancreatitis 
affected “molecular activity” of CatB and/or CatL.
Pancreatitis inhibits molecular activity of CatL in fractions contain-
ing autophagic vacuoles. For this analysis (see details in Methods), 
we examined whether the changes in activities of cathepsins in 
the subcellular fractions (Figure 7A) could be accounted for by 
changes in the levels of their active (processed) forms, assessed 
by immunoblot (Figure 6). We observed that CatL and CatB 
activities in the lysosome-enriched fraction L had a several-fold 
Figure 7
Effects of pancreatitis and fasting on CatL 
and CatB activities in subcellular fractions. 
Rats were subjected to conditions of fast-
ing and pancreatitis induced by CR or Arg, 
as described in Methods, and pancreatic 
subcellular fractions were obtained as in 
Figure 4. (A) CatL and CatB activities were 
measured by a fluorogenic enzymatic 
assay and expressed per milligram of pro-
tein in each fraction. (B) Comparison of 
the changes in the activities of cathepsins 
in the ZG-enriched fraction Z versus the 
amount of their active (processed) forms in 
this fraction. The values of CatL and CatB 
activities shown in A were normalized to 
those for the feeding conditions. Changes 
in the amount of active (processed) forms 
of cathepsins in fraction Z were assessed 
from densitometric quantification of their 
immunoblots, as described in Methods. 
Values are (mean ± SEM) from at least 3 
animals for each condition.
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decrease in pancreatitis, but there was little decrease in the total 
amount of their active forms in this fraction. This implies that 
pancreatitis causes an inhibition of CatL and CatB molecular 
activity in fraction L.
The effect of pancreatitis on the molecular activity of cathep-
sins in the ZG-enriched fraction Z was less clear, as the models of 
pancreatitis displayed increases in both the activity (per mg pro-
tein) and the amount of processed cathepsin forms in this frac-
tion (Figure 7B). For CatL, the increases in activity in fraction Z 
(up to ~2-fold increases compared with feeding conditions) were 
much smaller than the 4- to 6-fold increases in the amount of its 
active forms in this fraction (Figure 7B). These results indicate that 
pancreatitis partially inactivates CatL in fraction Z. The increase 
in CatB activity in fraction Z was comparable with CatL. However, 
in contrast with CatL, it was not accompanied by any significant 
increase in the amount of CatB active forms in fraction Z (Figure 
7B). This suggests that pancreatitis may stimulate CatB molecular 
activity in fraction Z.
With respect to the analysis in Figure 7B, we make no assump-
tion as to whether the partially processed (e.g., single-chain) 
Figure 8
Autophagy impairment mediates intra-acinar trypsin accumulation in pancreatitis. (A) Rat pancreatic acinar cells were incubated with or without 
100 nM CCK and 10 mM 3-MA. Trypsin activity after 30-minute incubation was measured in cell homogenates by a fluorogenic assay. LC3 dots 
were visualized, as illustrated in Figure 2B, and counted using ImageJ software. (B) Mouse acinar cells were transfected with Atg5 siRNA or 
control siRNA, as described in Methods. The transfection efficiency is illustrated in Figure 1F. Trypsin activity was measured under fluorescence 
microscope in live cells loaded with a trypsin substrate BZiPAR and incubated for 30 minutes with and without 100 nM CCK (see Supplemental 
Figure 6). The fluorescence from cleaved BZiPAR was measured per cross-sectioned cell area using ImageJ software, and 150–200 acinar cells 
were assessed for each condition. (C) Rats were subjected to CR pancreatitis and killed 30 minutes after the first CR injection. Pancreatic tissue 
sections were double immunostained for LC3 and TAP or LAMP-2 and TAP (colocalization shown by arrowheads). (D–F) Rats were subjected 
to fasting and CR or Arg pancreatitis (see Methods), and pancreatic subcellular fractions were obtained as in Figure 4. (D and E) Trypsin activity 
was measured in whole tissue homogenates or subcellular fractions by a fluorogenic assay. (F) TAP levels in fractions Z and L were measured 
by ELISA and in each fraction were normalized to those for the feeding conditions. Values in A, B, and D–F are mean ± SEM (n = 3).
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cathepsin form is more or less active than its fully mature, double-
chain form. The available data (9, 46) indicate that the “molecular 
activities” of single-chain cathepsin forms may be the same or even 
higher than of their double-chain forms.
In contrast to pancreatitis, fasting had no major effect on the 
“molecular activities” of CatL and CatB, compared with feeding 
conditions. In particular, the fasting-induced moderate increases 
in CatB and CatL activities in fraction Z were proportional to the 
levels of the active (processed) forms of cathepsins (Figure 7B).
Together, the results show that pancreatitis causes a pronounced 
decrease in the activity of CatL and CatB in the lysosome-enriched 
fraction L. Our analysis also indicates that pancreatitis inhibits 
CatL molecular activity in both fractions (Z and L) containing 
autophagic vacuoles. Inhibition of CatL activity may represent 
a key mechanism underlying pancreatitis-induced inhibition of 
lysosomal protein clearance and retardation of autophagic flux. 
Different from CatL, pancreatitis inhibits the molecular activity of 
CatB in fraction L but likely increases it in fraction Z.
Cathepsin inhibition promotes acinar cell vacuolation. Incubations 
of rat pancreatic acinar cells with E-64d (a potent inhibitor of 
both CatB and CatL), CA-074me (a specific inhibitor of CatB), or 
CLIK-148 (a specific inhibitor of CatL) (47) all caused a dramatic 
increase in the cross-sectional area occupied by vacuoles (Supple-
mental Figure 5). Interestingly, the vacuoles induced by E-64d were 
smaller than those induced by inhibition of each cathepsin alone 
(Supplemental Figure 5A). Correspondingly, the number of vacu-
oles increased to a greater extent with E-64d than with the selective 
inhibitors of CatB or CatL (Supplemental Figure 5C). The reason 
for these morphologic differences remains to be explored, but the 
observations suggest that inhibition of lysosomal hydrolases alone 
can cause acinar cell vacuolation.
Autophagy impairment mediates the pathological, intra-acinar 
accumulation of trypsin in pancreatitis
Impaired autophagy mediates intra-acinar trypsinogen activation. As stat-
ed above, the current paradigm for trypsinogen activation (19, 22, 
23) is that it is caused by CatB missorting, leading to its redistri-
bution to ZG-containing compartment(s). Our immunoblot data, 
however, did not show redistribution of active CatB. Alternatively, 
we hypothesized that there is a link between autophagy impair-
ment in pancreatitis and the intra-acinar trypsinogen activation.
Blocking autophagy induction with 3-MA completely prevent-
ed trypsinogen activation induced by CCK hyperstimulation of 
mouse pancreatic acinar cells (Figure 8A). (By counting LC3 dots in 
acinar cells, we confirmed that 3-MA in these experiments indeed 
blocked the CCK-induced autophagy [Figure 8A].) Further, siRNA 
knockdown of Atg5, a key mediator of autophagy induction (2, 
28), inhibited CCK-induced trypsinogen activation (Figure 8B and 
Supplemental Figure 6) to the same extent as it inhibited Atg5 
expression (Figure 1F, inset). A similar inhibition of trypsinogen 
activation has been recently reported (25) in pancreatic acinar cells 
isolated from Atg5-deficient mice.
In this context, we noticed that a number of dissimilar com-
pounds that have been shown to inhibit trypsinogen activation 
in models of acute pancreatitis share a common feature — they all 
inhibit autophagy but act through different mechanisms. These 
Figure 9
CatL but not CatB inhibits trypsin activity by degrading both trypsin and trypsinogen. (A–C) Effects of CatB and CatL on trypsinogen activation 
and degradation in cell-free system. Trypsinogen (A) or trypsin (B) was incubated for 2 hours with and without CatB or CatL, as described in 
Methods, and trypsin activity was measured by a fluorogenic assay. (C). Levels of trypsinogen and trypsin remaining after the 2-hour incubation 
with CatB or CatL were measured by immunoblot. (D) Rat pancreatic acinar cells were incubated for 30 minutes with and without 100 nM CCK, 
in the presence and absence of the specific CatL inhibitor CLIK-148 (20 mM). Trypsin activity was measured by a fluorogenic assay. Values 
in A, B, and D are mean ± SEM (n = 3). *P < 0.05 versus control cells; #P < 0.05 versus CCK alone. (E). Schematic illustrating the hypothesis 
that the pathological, intra-acinar trypsin accumulation results from an imbalance between the activities of CatB, which converts trypsinogen 
to trypsin, and CatL, which degrades both trypsin and trypsinogen. The stimulatory and inhibitory effects of pancreatitis on these enzymes are 
shown by (+) and (–) symbols, respectively.
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include the PI3-kinase inhibitors LY294002 and wortmannin (48, 
49) and the cytosolic Ca2+ chelators BAPTA/EGTA (50, 51), which 
all block autophagy induction (2, 3, 52), and bafilomycin, monen-
sin, and chloroquine (53), which dissipate pH gradients and thus 
block the fusion of lysosomes with autophagosomes (54). We 
confirmed that all these compounds blocked trypsinogen activa-
tion induced by CCK hyperstimulation in isolated rat pancreatic 
acinar cells (data not shown).
The immunofluorescence data indicated autophagic vacuoles 
make up one compartment, in which trypsinogen activation 
occurs in pancreatitis (Figure 8C). Both the autophagic marker 
LC3-II and the lysosomal marker LAMP-2 partly colocalized with 
trypsinogen activation peptide (TAP; an oligopeptide cleaved off 
trypsinogen in the process of its conversion to active trypsin).
In contrast to that found in pancreatitis, there was no trypsino-
gen activation in pancreas of rats fasted even for a long time, up 
to 64 hours (Figure 8D and Supplemental Figure 7). Similarly, 
there was no trypsinogen activation in pancreas of mice fasted 
for 24 hours (data not shown), a condition that greatly activates 
autophagy in the exocrine pancreas (28). Further, we observed 
that induction of autophagy with rapamycin, an inhibitor of 
mTOR (kinase that blocks initial stages of autophagy [refs. 2, 3]), 
increased neither the basal trypsin activity nor the CCK-induced 
trypsinogen activation in rat acinar cells (data not shown). These 
results indicate that autophagy activation by itself does not 
induce trypsinogen activation.
The distribution of trypsin activity in rat pancreatic subcellular 
fractions was very different for pancreatitis and fasting (Figure 
8E). In pancreas of fasted rats, the maximal trypsin activity was 
in the lysosome-enriched fraction L (the same as in normally 
fed rats), and the levels of active trypsin in all fractions did not 
change, compared with feeding conditions. In CR pancreatitis, 
trypsin activity in fraction L had an approximately 5-fold increase, 
but it was induced more than 40 fold in the ZG-enriched fraction 
Z (Figure 8E). Similar results were obtained with respect to TAP 
(Figure 8F): while fasting had no significant effect, CR pancre-
atitis caused TAP accumulation in fraction Z to a much greater 
extent than in fraction L.
The data in Figure 8 and Supplemental Figure 7 show that fast-
ing does not induce the pathological, intra-acinar trypsinogen acti-
vation, a hallmark of pancreatitis. On the other hand, the results 
with autophagy inhibitors or Atg5 inactivation (as well as ref. 25) 
indicate that autophagy is necessary for trypsinogen activation in 
acinar cells. Taken together, these findings strongly suggest that it 
is impaired autophagic function, but not autophagy activation per 
se, that mediates the pathological, intra-acinar accumulation of 
trypsin. Indeed, the observed increase in active trypsin in fraction 
Z can be explained by accumulation of “heavy”, ZG-containing 
autophagic vacuoles due to retarded autophagic flux in pancre-
atitis. Because our results implicated CatL inhibition as a mecha-
nism underlying the defective protein clearance in pancreatitis, we 
further hypothesized that CatL dysregulation is involved in the 
intra-acinar accumulation of trypsin.
CatL but not CatB degrades trypsin. To assess CatL involvement 
in trypsinogen activation, we first compared the effects of CatB 
and CatL on the trypsinogen conversion to trypsin, as well as the 
proteolytic degradation of trypsin and trypsinogen, in a cell-free 
system. In these experiments (Figure 9, A–C), we used the same 
amount of activity units for CatL and CatB with trypsin or trypsin-
ogen as substrates. CatB efficiently converted trypsinogen to active 
trypsin (Figure 9A), as previously reported (19, 38, 39). At the same 
time, CatB neither inhibited the activity of recombinant trypsin 
(Figure 9B) nor caused any significant degradation of trypsin or 
trypsinogen (Figure 9C). The effects of CatL were exactly oppo-
site (Figure 9, A–C). CatL did not convert trypsinogen into tryp-
sin (even at 5 times greater concentration; data not shown), but it 
efficiently degraded both trypsin and trypsinogen and markedly 
decreased trypsin activity. These findings are in accordance with 
preliminary reports by Lerch, Halangk, and colleagues (40–42), 
which indicate that CatL can degrade trypsin and trypsinogen.
We next measured the effects of a specific CatL inhibitor, CLIK-
148 (which does not affect CatB [ref. 47]), on trypsinogen activa-
tion in CCK-hyperstimulated acinar cells. CLIK-148 significantly 
increased both the basal and CCK-induced trypsin activity (Figure 
9D), indicating that CatL negatively regulates trypsinogen activa-
tion in acinar cells.
Based on these findings, we propose that the pathological, 
intra-acinar accumulation of trypsin in pancreatitis is caused by 
an imbalance between the enhanced CatB-mediated trypsinogen 
conversion to trypsin and the inefficient degradation of trypsin 
and trypsinogen by CatL. This hypothesis is illustrated in the sche-
matic in Figure 9E.
Discussion
To examine the role of autophagy in acute pancreatitis, this study 
compared autophagic responses in in vivo and in vitro experimental 
models of pancreatitis with the physiological autophagy induced 
by fasting. Our findings revealed striking differences in autophagy 
characteristics between the 2 conditions, which led us to conclude 
that autophagy is impaired in acute pancreatitis. (a) Pancreatitis 
caused accumulation in acinar cells of large vacuoles (many-fold 
larger than in fasted animals), containing partially degraded mate-
rial. Accumulation of such vacuoles is a manifestation of retarded 
progression/resolution of autophagy (3). (b) Autophagic protein 
degradation was markedly inhibited in the in vitro model of pan-
creatitis. (c) Further evidence for retarded autophagic flux was the 
dramatic accumulation of lysosomal markers Rab7 and LAMPs in 
the heavier, ZG-enriched fraction that we found in both CR and 
Arg pancreatitis. This observation is consistent with accumulation 
of heavy autolysosomes (containing incompletely degraded mate-
rial) due to inefficient lysosomal clearance. In contrast, fasting did 
not affect the subcellular distribution of lysosomal markers. (d) 
Finally, we found that processing/maturation of CatL and CatB is 
impaired in pancreatitis but not with fasting.
We considered 2 mechanisms that might underlie autophagic 
flux impairment in pancreatitis. One possibility could be the 
blockade of autophagosome fusion with lysosomes, which occurs 
in lysosomal diseases (10). However, the presence of a great num-
ber of vacuoles with partially degraded material in pancreas of ani-
mals with pancreatitis as well as in human tissue argues against 
this possibility. Indeed, we found that colocalization of the lyso-
somal markers Rab7 and LAMP-2 with the autophagic marker 
LC3-II increased in models of pancreatitis, which would not occur 
if autolysosome formation were blocked. The increased colocaliza-
tion, however, is consistent with retarded autophagy progression.
Another mechanism for the impaired autophagic flux in pancre-
atitis is a decreased activity of lysosomal hydrolases, resulting in 
inefficient lysosomal clearance. Evidence to support this mecha-
nism is provided by our finding that processing/maturation of 
CatL and CatB is defective in pancreatitis. For both cathepsins, 
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pancreatitis caused a shift from fully processed, double-chain 
form toward immature, single-chain form. The effect was most 
pronounced for CatL, resulting in the appearance of its immature 
form. The impaired cathepsin processing was associated with a 
dramatic decrease in CatL and CatB activities in the lysosome-
enriched fraction L in both CR and Arg pancreatitis. By contrast, 
fasting did not cause any abnormal cathepsin processing, and the 
maximal activities of both CatL and CatB remained in fraction L, 
same as in normal pancreas.
Pancreatitis affected the levels of cathepsins in the pancreatic tis-
sue subcellular fractions. The effect was more dramatic for CatL, 
resulting in accumulation of its active (processed) forms in the 
ZG-enriched fraction Z. In contrast, there was no redistribution of 
CatB protein (as shown using Western blot) from fraction L to Z, 
in either CR or Arg pancreatitis. By combining the measurements 
of protein levels and activities of cathepsins, we further showed 
that the molecular activity of CatL was reduced in both fractions 
L and Z, i.e., the fractions containing autophagic vacuoles. Differ-
ently, our analysis indicated that the molecular activity of CatB 
was inhibited in fraction L but might be increased in fraction Z.
The differences in the effect of pancreatitis on CatL and CatB 
processing and subcellular distribution may be related to the 
known differences in endolysosomal traffic and maturation 
of these cathepsins (5). As a rule, active CatL exists as its fully 
mature, double-chain form in lysosomes, whereas active CatB is 
present as both single- and double-chain forms and localizes to 
not only lysosomes but also prelysosomal structures (5). Thus, 
the greater effect of pancreatitis on CatL, compared with that on 
CatB, might indicate that pancreatitis affects lysosomes more 
than prelysosomal structures.
Taken together, the results suggest that defective cathepsin pro-
cessing and activities may underlie the inefficient protein degra-
dation and retarded autophagy progression in pancreatitis. The 
mechanism(s) responsible for the defective cathepsin processing 
and activities in pancreatitis remain to be established.
Our results indicate that impaired autophagy mediates 2 key 
pathological events of pancreatitis: acinar cell vacuolation and 
intra-acinar trypsin accumulation. Acinar cell vacuolation is a 
long noted but poorly understood manifestation of pancreatitis. 
Studies from decades ago (14–17) used terms such as “autopha-
gic vacuoles”; however, both the identity of these vacuoles and 
the mechanisms triggering their formation have not been estab-
lished. Our data show that blocking autophagy with 3-MA or 
Atg5 inactivation greatly inhibits vacuolation of acinar cells, 
thus indicating that autophagic vacuoles are indeed a major type 
of vacuoles in pancreatitis. These results corroborate the recent 
study (25), which showed that Atg5-knockout mice displayed 
a marked decrease in acinar cell vacuolation in the CR model. 
However, that study did not consider autophagy impairment 
but instead concluded that acinar cell vacuolation is caused by 
“excessive” autophagy activation in pancreatitis. This conclusion 
was based on the observed increases in the level of LC3-II and 
the number of LC3-positive vacuoles (25). The pancreatitis mod-
els we studied also displayed increases in LC3-II levels and the 
number of LC3-positive vacuoles. However, as shown in many 
publications (26), these parameters cannot be used as a measure 
of autophagy activation, as such increases may result from either 
autophagy activation or its impairment. It is also worth noting 
that when autophagy progression/resolution is impaired its acti-
vation becomes “excessive.”
The comparison with the physiological autophagy response 
induced by fasting indicates that it is not autophagy activation per 
se but its impairment (and in particular, the defective cathepsin 
processing) that is responsible for the pathological manifestations 
of acute pancreatitis. Indeed, we show that inhibition of both CatB 
and CatL causes a dramatic increase in vacuoles in acinar cells. In 
fact, pharmacologic or genetic inactivation of cathepsins has been 
shown in other cells to block autophagy progression, resulting in 
accumulation of autophagic vacuoles (3, 47, 55). The broad-spec-
trum cathepsin inhibitor, leupeptin, caused accumulation of large 
autophagic vacuoles in pancreatic acinar cells (56).
For many years, the only established mechanism underlying intra-
acinar accumulation of active trypsin in pancreatitis has been an 
increase in trypsinogen conversion to trypsin by CatB (38, 39). The 
current “colocalization hypothesis,” proposed by Steer and Saluja 
(19, 22, 23), postulates that this increase is caused by defective segre-
gation (“missorting”) of CatB, which leads to its redistribution into 
ZG-containing compartment(s). Thus, colocalization of CatB with 
trypsinogen is proposed to be a key initiating event of pancreatitis 
(19, 21, 22). Of note, redistribution of CatB into ZG-containing frac-
tion Z was inferred from changes in CatB activity in the subcellular 
fractions (30, 36) and not from direct measurement of CatB pro-
tein levels in models of pancreatitis. The colocalization hypothesis 
received criticism, in part because a significant CatB activity in frac-
tion Z is also observed in normal pancreas (20, 21, 36, 57).
Importantly, our immunoblot data show no redistribution of 
CatB into the ZG-enriched fraction Z in pancreatitis and indicate 
that the observed changes in CatB activity result from its’ abnormal 
processing. These findings argue against the colocalization hypoth-
esis. Alternatively, we propose that in the normal process of autoph-
agy, ZGs undergo autophagic degradation, and thus a part of them 
become sequestered in autophagic vacuoles, as evidenced by EM (28) 
and colocalization of amylase with LC3-II (see Results). This is the 
site in which CatB “meets” and activates trypsinogen, resulting in 
the low basal trypsin activity in normal pancreas. Hence, colocaliza-
tion of cathepsins with ZG is itself not pathological. In physiological 
autophagy (i.e., fasting), this colocalization does not lead to exces-
sive accumulation of active trypsin, because trypsinogen activation 
is balanced by efficient lysosomal degradation of sequestered ZG 
content. By contrast, in pancreatitis, trypsin accumulates in acinar 
cells due to deficient autophagic protein degradation.
Our hypothesis explains the findings in the present study and 
ref. 25 that autophagy inhibition by pharmacologic, molecular, 
and genetic means abrogated trypsinogen activation in acinar 
cells, which demonstrated the involvement of autophagy. We fur-
ther detected TAP colocalization with LC3-II and LAMP-2 in CR 
pancreatitis, indicating autophagic vacuoles as one site of the intra-
acinar cell trypsinogen activation. The finding in our study that 
pancreatitis induces accumulation of multiple lysosomal markers 
(not only cathepsins but also Rab7 and LAMPs) in the ZG-enriched 
fraction Z is difficult to explain by cathepsin missorting.
Our results suggest that trypsin accumulates in acinar cells due 
to disturbed equilibrium between its generation from trypsinogen, 
mediated by CatB, and the degradation of trypsin and trypsinogen 
by CatL (and possibly, other cathepsins). According to our hypoth-
esis, such imbalance is caused by defective processing and activities 
of cathepsins in pancreatitis and not by “excessive” autophagy acti-
vation, as suggested in ref. 25. Indeed, our data show that physi-
ological autophagy does not lead to intra-pancreatic accumulation 
of active trypsin, even with prolonged fasting.
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In sum, we provide evidence that acute pancreatitis causes pro-
found autophagy impairment, which is responsible for 2 key mani-
festations of this disease: the accumulation of large vacuoles in aci-
nar cells and the intra-acinar trypsinogen activation. Specifically, 
our findings indicate that pancreatitis causes inefficient protein 
clearance, leading to retarded progression (a “traffic jam”) from 
autophagosomes to autolysosomes. The results suggest that one 
mechanism mediating autophagic flux retardation in pancreati-
tis is the impaired processing and activity of cathepsins. Further-
more, autophagy impairment may be a manifestation of a more 
general phenomenon, indicating that the endolysosomal traffic 
is disordered in acute pancreatitis. Indeed, trypsinogen activation 
has been recently reported (51) in endocytic vacuoles in response to 
CCK hyperstimulation of acinar cells. A number of characteristics 
of pancreatitis are similar to those observed in lysosomal disorders 
(which are mostly caused by mutations that inactivate lysosomal 
hydrolases or affect their delivery to lysosomes) — such as block of 
autophagy, impaired maturation of cathepsins, decreased protein 
degradation, cell vacuolation and death, and the inflammatory 
response (10). Thus, our findings indicate that acute pancreatitis 
has features of a lysosomal disease, which should be taken into con-
sideration in designing strategies to treat or mitigate pancreatitis.
Methods
Reagents. Antibodies against LC3, LAMP-1, Beclin1, and CatB were from 
Santa Cruz Biotechnology Inc.; antibody against LAMP-2 was from Sigma-
Aldrich; antibodies against Rab7, Atg5, and p44/42 MAP kinase (ERK1/2) 
were from Cell Signaling Technology; antibody against EEA1 was from 
BD Biosciences; antibody against COX IV was from Molecular Probes; 
antibody against trypsinogen was from Chemicon–Millipore; antibody 
against PDI was from Stressgen. The antibody against CatL was developed 
by A.H. Erickson. CCK was from American Peptide; CR was from Penin-
sula Laboratories; Arg was from Sigma-Aldrich; liver CatB (0.25 units/mg 
protein) and CatL (1 unit/mg protein) were from Calbiochem; bovine 
pancreas trypsinogen was from Sigma-Aldrich; recombinant trypsin was 
from Roche; BZiPAR [rhodamine 110 bis-(CBZ-l-isoleucyl-l-prolyl-argi-
nine amide) dihydrochloride] was from Molecular Probes. CatB inhibitor 
CA-074me was from Calbiochem; the selective CatL inhibitor CLIK-148 
was developed by N. Katunuma. Fluorogenic substrates for CatB (Z-Arg-
Arg-AMC) and CatL (Z-Phe-Arg-AMC) were from Calbiochem; trypsin 
specific substrate, Boc-Gln-Ala-Arg-AMC, was from Biomol International. 
All other reagents were from Sigma-Aldrich.
Experimental pancreatitis. Cerulein pancreatitis was induced as described 
(31), in male (200–250 g) Sprague-Dawley rats and in CD-1 or transgenic 
GFP-LC3 (28) mice (25–30 g) (a gift from N. Mizushima, Tokyo Medical 
and Dental University, Tokyo, Japan, and RIKEN BioResourse Center, 
Koyadai, Japan. Rats received 4 and mice received 7 hourly i.p. injections of 
50 μg/kg CR. Control animals received similar injections of physiological 
saline. The animals were fasted overnight (for 17 hours). Arginine pancre-
atitis was induced in rats as described (31), with 2 hourly i.p. injections of 
2.5 g/kg Arg; controls received similar injections of saline. In this model, 
rats were not fasted and were sacrificed 24 hours after the first injection. 
CDE pancreatitis (58) was induced in young (14–15 g) female CD-1 mice 
fed either CDE or control diet. Fresh aliquots of the diets were provided 
every 12 hours, and the food intake was measured. Mice were sacrificed 48 
or 72 hours after initiation of the diet.
Animals were euthanized by CO2-induced asphyxiation, and the blood 
and pancreas were harvested for measurements. The development of pan-
creatitis was confirmed by histological changes and by increased levels of 
amylase and lipase in serum, as measured in a Hitachi 707 analyzer (Antech 
Diagnostics). The experimental protocols were approved by the animal 
research committee of the Veterans Affairs Greater Los Angeles Healthcare 
System, in accordance with the NIH guidelines.
Fasting. In fasting experiments, we took into account the nocturnal eat-
ing habits of rodents. It has been shown, for example, that the number 
and size of ZGs in exocrine pancreas (59) and the amylase content in the 
functionally similar parotid gland (60) all increase during the day and then 
markedly decrease during the nocturnal feeding period. Thus, for normally 
fed controls, we used animals sacrificed at 5 PM, that is, prior to start of the 
nocturnal feeding period. Fasting animals were deprived of food (labora-
tory chow) overnight and euthanized either at 10 AM next day (after 17 
hours fasting) or 5 PM (after 24 hours fasting). These fasting times encom-
pass the duration of CR pancreatitis experiments. In some experiments, 
rats were deprived of food for longer times, up to 64 hours.
Isolation of pancreatic acinar cells. Isolation of cells from rats or mice was 
performed using a collagenase digestion procedure as described (31, 49, 
61). Dispersed pancreatic acini were then incubated at 37°C in 199 medi-
um in the presence or absence of CCK and other agents as indicated.
Prolonged culture of acinar cells. Mouse pancreatic acinar cells, isolated 
using standard collagenase digestion procedure (31, 49, 61), were cultured 
(for up to 3 days) according to ref. 32, on collagen IV in DMEM medium 
containing 15% FBS, 5 ng/ml EGF, 0.25 μg/ml amphotericin B, 0.5 mM 
IBMX, 0.2 mg/ml soybean trypsin inhibitor, 100 U/ml penicillin, and 
100 μg/ml streptomycin. We used the prolonged (24-hour) acinar cell cul-
ture for transfections and measurement of long-lived protein degradation 
(see below). As shown in Supplemental Figure 8, these cells retained acinar 
cell phenotype and functional responses. In particular, they released amy-
lase upon CCK stimulation and, moreover, retained the hallmark biphasic 
response curve that displays inhibited amylase release at supramaximal 
CCK concentrations (Supplemental Figure 8D). Further, the supramaxi-
mal CCK induced trypsinogen activation in cultured acinar cells (Supple-
mental Figure 8E) to a similar extent as that in freshly isolated cells.
The prolonged culture caused some damage in acinar cells. For exam-
ple, after 24-hour culture, vacuoles (assessed on cell sections stained with 
toluidine blue) occupied 1.6% ± 0.4% of cross-sectional cell area, compared 
with 0.7% ± 0.2% of cross-sectional cell area in freshly isolated mouse acinar 
cells. Only the number, but not the average size of vacuoles in acinar cells, 
increased during culture (both measured with the use of ImageJ software; 
http://rsbweb.nih.gov/ij/). Necrosis (measured by trypan blue exclusion) 
increased to 12% ± 3% after 24-hour culture, compared with 4% ± 2% necro-
sis in freshly isolated mouse acinar cells. (Values are means ± SEM from 
100–150 acinar cells in at least 3 separate acinar cell preparations.)
Transfections. Acinar cells in prolonged culture (see above) were trans-
fected with Atg5 siRNA by using ON-TARGETplus SMARTpool 
from Dharmacon, consisting of equal amounts of 4 RNA duplexes 
targeting the gene of interest (i.e., Atg5). The Atg5 siRNA sequences 





For negative control, we used siCONTROL Non-Targeting pool; for positive 
control, we used the siGLO Cyclophilin B siRNA, labeled with fluorescent 
DY547 (all from Dharmacon). Transfections (100 pmoles of each siRNA) 
were performed using the Amaxa Nucleofactor electroporation system 
(Amaxa Transfection). The transfection efficiency, assessed by using siGLO 
cyclophilin B siRNA (Supplemental Figures 6 and 8), was 50%–70%. Trans-
fected cells preserved acinar cell phenotype (Supplemental Figure 8) and 
responded to CCK with increases in vacuoles (Figure 1F) and trypsinogen 
activation (Figure 8B and Supplemental Figure 6).
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The electroporation procedure, using the Amaxa Nucleofactor system, 
increased necrosis to 30% ± 8% (as measured by trypan blue exclusion), com-
pared with 12% ± 3% in nontransfected acinar cells after 24-hour culture. 
This increase was due to electroporation and not transfection per se. Impor-
tantly, the extent of necrosis was the same in cells transfected with control 
and Atg5 siRNA. Also, there was no effect of transfections on acinar cell 
vacuolation. Of note, all the measurements on transfected cells were per-
formed under the microscope, in cells with an intact plasma membrane.
Subcellular fractionation. Subcellular fractionation of pancreatic tissue 
was performed by differential centrifugation as described by Saluja and 
colleagues (30, 36). The dissected pancreas was homogenized in 8 ml of 
homogenization buffer with 5 full strokes, and the nuclei and cell debris 
were sedimented at 150 g. The postnuclear supernatant was centrifuged at 
1,300 g, and the pellet collected was referred to as fraction Z (see Results). The 
supernatant was further centrifuged at 12,000 g, and both the 12,000-g pellet 
(fraction L) and supernatant (fraction E) were collected. Total protein in the 
fractions was measured by Bradford assay (Bio-Rad). Of note, fractions Z and 
L contained essentially the same amount of total protein, whereas this was 
approximately 4 times greater in fraction E. The amounts of total protein in 
the fractions were consistent across experimental conditions.
EM. For EM, the tissue (cut into 1-mm cubes) or the pellets from the 
subcellular fractions were fixed at 4°C in 2.5% glutaraldehyde in 0.15 M 
sodium cacodylate (pH 7.4) overnight. After postfixation in 1% OsO4, fol-
lowed by uranyl acetate, tissue was dehydrated in ethanol and embedded in 
epoxy resin. Then, 100-nm-thick sections were stained with uranyl acetate 
and examined in a Hitachi-600 electron microscope. For quantification, 
the areas of each autophagic vacuole and nucleus were measured on each 
print, and the average size of autophagic vacuoles was normalized to that 
of the nuclei in the same electron micrograph.
Immunogold EM. For immunogold labeling, pancreata from GFP-LC3 
transgenic mice (28) were fixed in 4% buffered formaldehyde (pH 7.2). The 
tissue pieces were then either embedded in LR White resin using a micro-
wave-assisted protocol (62) or were cryoprotected in dimethyl formamide, 
frozen in liquid propane, freeze substituted in dry acetone containing 
1% OsO4, and embedded in Lowicryl HM20. The embedded tissues were 
sectioned, mounted onto metal specimen grids, and immunolabeled by 
using goat anti-LC3 antibodies. Sections were visualized using a bridging, 
unconjugated rabbit anti-goat antibody followed by 10 nm protein A-gold 
(University of Utrecht, Utrecht, The Netherlands). Sections were stained 
with uranyl acetate and lead citrate to enhance contrast.
Light microscopy. For histological evaluation (31), pancreatic tissue was 
fixed in 10% buffered formaldehyde, embedded in paraffin, sectioned, and 
stained with H&E. Images were captured with a Nikon Eclipse TE2000-S 
microscope equipped with a CCD camera, using the SPOT imaging soft-
ware (Diagnostic Instruments). The number of vacuoles and the percent-
age of cross-sectioned cell area occupied by vacuoles on pancreatic tissue 
sections were quantified using MetaMorph 6.1 software. The number of 
vacuoles in isolated acinar cells was quantified on cells stained with tolu-
idine blue as described in ref. 63. H&E images of pancreatic tissue from 
patients with acute pancreatitis were provided by D.S. Longnecker.
Immunofluorescence. For immunolabeling, pancreas was dissected and fixed 
for 2 hours in 4% paraformaldehyde, and tissue pieces were equilibrated for 
2 hours at 4°C in a 15% sucrose-phosphate buffer solution and then embed-
ded in OCT compound (Miles). Then, 5-μm frozen pancreatic tissue sections 
were fixed in 0.1 M phosphate buffer containing 4% paraformaldehyde, 
washed several times in PBS supplemented with 0.5% saponin and 0.2% 
Tween-20, and blocked with 2% donkey serum. Tissue sections then incubat-
ed overnight with primary antibody, followed by incubation with secondary 
antibody conjugated with FITC or Texas Red (Jackson ImmunoResearch Lab-
oratories). A different procedure (64) was applied for TAP immunolabeling.
Images were acquired with a Zeiss LSM 510 confocal microscope using 
a ×63 objective. To determine the percentage colocalization of 2 proteins, 
images obtained with the use of corresponding antibodies were loaded 
into ImageJ software (http://rsbweb.nih.gov/ij/) and the ratios of green 
(FITC) or red (Texas Red) cells to merged cells were determined with the 
colocalization plug-in.
Measurement of the rate of long-lived protein degradation. The long-lived protein 
degradation rate was measured as described by Mizushima and Mortimore 
and colleagues (27, 65). Mouse pancreatic acinar cells, isolated using stan-
dard collagenase digestion procedure (31, 49, 61), were first cultured for 
6 hours as specified above (see Prolonged culture of acinar cells), on collagen IV 
in DMEM medium supplemented with [14C]-valine (4 mCi/mmol specific 
activity); washed by centrifugation to remove unincorporated radioisotope 
and the released amino acids; and then the cells were replated on collagen IV 
and chased for 16 hours in fresh DMEM medium containing 2 mM cold 
valine, during which time all short-lived proteins were degraded (65, 66). 
After that, cells were washed 3 times by centrifugation in 199 medium con-
taining 2 mM cold valine and further incubated on plastic for 4 hours in 
either 199 medium (i.e., containing amino acids) with or without CCK (as 
indicated in Figure 3) or “nutrient-free” medium devoid of amino acids 
(Sigma-Aldrich), which is used for in vitro starvation experiments.
For each condition, parallel incubations were done with or without the 
autophagy inhibitor 3-MA (10 mM). The purpose of using 3-MA is to quan-
tify protein degradation by both autophagic and nonautophagic mechanisms 
(27). The values obtained in the presence of 3-MA were subtracted as the non-
autophagic background, producing the net autophagy-mediated rate of long-
lived protein degradation. At the end of incubation, protein in both the cells 
and the incubation medium was precipitated with ice-cold 10% (v/v) trichlo-
roacetic acid (TCA). The soluble radioactivity, which represents degradation 
products, was separated from intact protein by centrifugation at 12,000 g for 
10 minutes. The rate of long-lived protein degradation was calculated as the 
percentage of TCA-soluble radioactivity in both the medium and cells (27).
Measurement of protease activities. Cathepsin activities were measured in 
pancreatic tissue homogenates and subcellular fractions as described in 
ref. 67, using fluorogenic substrates specific for CatB (Z-Arg-Arg-AMC) 
or CatL (Z-Phe-Arg-AMC) (50 μM each). CatB activity was measured in 
50 mM phosphate buffer, pH 6.0, and CatL activity was measured in 100 mM 
sodium acetate buffer, pH 5.5, in the presence of 2 mM EDTA and 2 mM 
DTT. In measurements of CatL activity, the assay buffer also contained 
50 μM CA-074me, a CatB inhibitor.
Trypsin activity was measured in tissue and cell homogenates or sub-
cellular fractions using a specific fluorogenic substrate, Boc-Gln-Ala-Arg-
AMC, as described (49, 68). Trypsin activity in live pancreatic acinar cells 
was measured by using the fluorogenic substrate BZiPAR, as described 
(69). All solutions for this assay contained 5 μM soybean trypsin inhibi-
tor. Images were obtained in a Nikon Eclipse TE2000-S microscope, 
and fluorescence quantification was performed using ImageJ software 
(http://rsbweb.nih.gov/ij/).
TAP measurements. TAP measurements were performed in pancreatic tissue 
homogenates and subcellular fractions with ELISA (Biotrin International).
Measurements of cathepsin-induced conversion of trypsinogen to trypsin and deg-
radation of trypsin and trypsinogen in cell-free system. Trypsinogen (2 μM) or 
trypsin (0.2 μM) was incubated for 2 hours at 37°C, with 5 mU CatB or 
CatL in 0.1 M sodium acetate buffer containing 2 mg/ml BSA and 1 mM 
EDTA at pH 4.0 or 5.5, respectively. Before use, cathepsins were activated 
by incubating them on ice for 30 minutes with 1 mM DTT. Enterokinase 
(0.05 U/μg protein in 0.2 M Tris-HCl, 20 mM CaCl2, pH 7.4) was used as a 
positive control. We measured both the resulting trypsin activity, by using 
the fluorogenic Boc-Gln-Ala-Arg-AMC substrate (49, 68), and the levels of 
trypsinogen and trypsin by immunoblot.
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Amylase secretion by isolated acinar cells. Amylase secretion by isolated aci-
nar cells (Supplemental Figure 8D) was measured spectrophotometrically 
using Phadebas amylase kit (Magle AB), as described previously (49). Values 
for amylase secretion are ratios between the amount of amylase released 
into the extracellular medium and the total cellular amylase determined 
by permeabilizing cells with 1% Triton X-100.
Western blot analysis. Western blot analysis was performed on tissue and 
cell homogenates or subcellular fractions as described previously (31, 61). 
Proteins were separated by SDS-PAGE and electrophoretically transferred 
to nitrocellulose membranes. Nonspecific binding was blocked by 1-hour 
incubation of the membranes in 5% (w/v) nonfat dry milk or 5% BSA in 
Tris-buffered saline (pH 7.5). The blots were then incubated for 2 hours 
or overnight with primary antibodies in the antibody buffer containing 
1% (w/v) nonfat dry milk in 0.05% (v/v) Tween 20 in Tris-buffered saline 
(TTBS), washed 3 times with TTBS, and finally incubated for 1 hour with 
a peroxidase-labeled secondary antibody in the antibody buffer. The blots 
were developed for visualization using an enhanced chemiluminescence 
detection kit (Pierce). Band intensities in the immunoblots were quantified 
by densitometry using the Scion image analysis software (Scion Co.).
When comparing immunoblots of the whole pancreatic tissue and 
subcellular fractions, keep in mind that the 3 fractions do not contribute 
equally to a Western blot of the whole tissue, as the total amount of protein 
differs among the fractions (see Subcellular fractionation). Thus, the tissue 
immunoblot is not a simple sum of those for individual fractions.
Analysis of the amounts of CatL and CatB active forms in pancreatic subcellular 
fractions by immunoblot. Two methods were used to assess changes in the active 
(processed) forms of cathepsins in pancreatic subcellular fractions, based on 
densitometric intensity of their bands in the immunoblots (see Figure 7B). 
First, for each sample and for each cathepsin (i.e., CatL or CatB), we calculat-
ed the ratio of band intensity of the active forms (single- or double-chain or 
both together) in a given fraction to the sum of these intensities in all 3 sub-
cellular fractions. The means of these ratios for each condition (e.g., CR pan-
creatitis or fasting) were further normalized to those for feeding conditions. 
For example, the mean value for CatB active forms in fraction Z, calculated 
as the percentage of the total amount of CatB active forms in all 3 fractions, 
was 34% in CR pancreatitis versus 45% in rats fasted for 17 hours versus 43% 
in normally fed rats (see Figure 7B). As a second method, we calculated the 
ratios of band intensity of CatL (or CatB) active forms to its proform in the 
same subcellular fraction. The mean values for these ratios showed a similar 
trend of changes; for example, the mean ratio of CatB active forms to its pro-
form in fraction Z was 2.5 in CR pancreatitis versus 3.6 in fasted rats.
Statistics. Results represent means ± SEM from several independent 
experiments, as specified in figure legends. Differences between 2 groups 
were analyzed using 2-tailed Student’s t test. P values of less than 0.05 were 
considered statistically significant.
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